{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:06:42Z","timestamp":1786540002143,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":43,"publisher":"Springer US","isbn-type":[{"value":"9781071624524","type":"print"},{"value":"9781071624531","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2453-1_10","type":"book-chapter","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T19:03:05Z","timestamp":1657652585000},"page":"127-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Simple Bioluminescent Assay for the Screening of Cytotoxic Molecules Against the Intracellular Form of Leishmania infantum"],"prefix":"10.1007","author":[{"given":"Diego","family":"Ben\u00edtez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Quiroga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo A.","family":"Comini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002865","volume":"8","author":"PJ Hotez","year":"2014","unstructured":"Hotez PJ, Alvarado M, Bas\u00e1\u00f1ez MG et al (2014) The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis 8:e2865. https:\/\/doi.org\/10.1371\/journal.pntd.0002865","journal-title":"PLoS Negl Trop Dis"},{"key":"10_CR2","unstructured":"World Health Organization (2020) Leishmaniasis. In: Facts sheets. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/leishmaniasis. Accessed 1 Apr 2021"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1017\/S003118201300142X","volume":"141","author":"R Don","year":"2014","unstructured":"Don R, Ioset JR (2014) Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections. Parasitology 141:140\u2013146. https:\/\/doi.org\/10.1017\/S003118201300142X","journal-title":"Parasitology"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ijpddr.2018.09.006","volume":"8","author":"LM Alc\u00e2ntara","year":"2018","unstructured":"Alc\u00e2ntara LM, Ferreira TCS, Gadelha FR, Miguel DC (2018) Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis. Int J Parasitol Drugs Drug Resist 8:430\u2013439. https:\/\/doi.org\/10.1016\/j.ijpddr.2018.09.006","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001253","volume":"5","author":"G De Muylder","year":"2011","unstructured":"De Muylder G, Ang KKH, Chen S et al (2011) A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit. PLoS Negl Trop Dis 5:e1253. https:\/\/doi.org\/10.1371\/journal.pntd.0001253","journal-title":"PLoS Negl Trop Dis"},{"key":"10_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001671","volume":"6","author":"JL Siqueira-Neto","year":"2012","unstructured":"Siqueira-Neto JL, Moon S, Jang J et al (2012) An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages. PLoS Negl Trop Dis 6:e1671. https:\/\/doi.org\/10.1371\/journal.pntd.0001671","journal-title":"PLoS Negl Trop Dis"},{"key":"10_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002154","volume":"7","author":"N Aulner","year":"2013","unstructured":"Aulner N, Danckaert A, Rouault-Hardoin E et al (2013) high content analysis of primary macrophages hosting proliferating leishmania amastigotes: application to anti-leishmanial drug discovery. PLoS Negl Trop Dis 7:e2154. https:\/\/doi.org\/10.1371\/journal.pntd.0002154","journal-title":"PLoS Negl Trop Dis"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1128\/AAC.02398-12","volume":"57","author":"M De Rycker","year":"2013","unstructured":"De Rycker M, Hallyburton I, Thomas J et al (2013) Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay. Antimicrob Agents Chemother 57:2913\u20132922. https:\/\/doi.org\/10.1128\/AAC.02398-12","journal-title":"Antimicrob Agents Chemother"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/adt.2015.652","volume":"13","author":"MJ Dagley","year":"2015","unstructured":"Dagley MJ, Saunders EC, Simpson KJ, McConville MJ (2015) high-content assay for measuring intracellular growth of leishmania in human macrophages. Assay Drug Dev Technol 13:389\u2013401. https:\/\/doi.org\/10.1089\/adt.2015.652","journal-title":"Assay Drug Dev Technol"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature19339","volume":"537","author":"S Khare","year":"2016","unstructured":"Khare S, Nagle AS, Biggart A et al (2016) Proteasome inhibition for treatment of leishmaniasis, chagas disease and sleeping sickness. Nature 537:229\u2013233. https:\/\/doi.org\/10.1038\/nature19339","journal-title":"Nature"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41598-018-36944-6","volume":"9","author":"S Lamotte","year":"2019","unstructured":"Lamotte S, Aulner N, Sp\u00e4th GF, Prina E (2019) Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening. Sci Rep 9:438. https:\/\/doi.org\/10.1038\/s41598-018-36944-6","journal-title":"Sci Rep"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.3390\/molecules25112551","volume":"25","author":"LM Alc\u00e2ntara","year":"2020","unstructured":"Alc\u00e2ntara LM, Ferreira TCS, Fontana V et al (2020) A multi-species phenotypic screening assay for leishmaniasis drug discovery shows that active compounds display a high degree of species-specificity. Molecules 25:2551. https:\/\/doi.org\/10.3390\/molecules25112551","journal-title":"Molecules"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens9050393","volume":"9","author":"KH Baek","year":"2020","unstructured":"Baek KH, Piel L, Rosazza T et al (2020) Infectivity and drug susceptibility profiling of different leishmania-host cell combinations. Pathogens 9:1\u201316. https:\/\/doi.org\/10.3390\/pathogens9050393","journal-title":"Pathogens"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/J.AB.2009.09.009","volume":"396","author":"BR Branchini","year":"2010","unstructured":"Branchini BR, Ablamsky DM, Davis AL et al (2010) Red-emitting luciferases for bioluminescence reporter and imaging applications. Anal Biochem 396:290\u2013297. https:\/\/doi.org\/10.1016\/J.AB.2009.09.009","journal-title":"Anal Biochem"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0002571","volume":"7","author":"AP McLatchie","year":"2013","unstructured":"McLatchie AP, Burrell-Saward H, Myburgh E et al (2013) Highly sensitive in vivo imaging of trypanosoma brucei expressing \u201cred-shifted\u201d luciferase. PLoS Negl Trop Dis 7:1\u201312. https:\/\/doi.org\/10.1371\/journal.pntd.0002571","journal-title":"PLoS Negl Trop Dis"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/cmi.12297","volume":"16","author":"MD Lewis","year":"2014","unstructured":"Lewis MD, Fortes Francisco A, Taylor MC et al (2014) Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection. Cell Microbiol 16:1285\u20131300. https:\/\/doi.org\/10.1111\/cmi.12297","journal-title":"Cell Microbiol"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0007133","volume":"13","author":"R \u00c1lvarez-Velilla","year":"2019","unstructured":"\u00c1lvarez-Velilla R, Guti\u00e9rrez-Corbo M, Punz\u00f3n C et al (2019) A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery. PLoS Negl Trop Dis 13:1\u201315. https:\/\/doi.org\/10.1371\/journal.pntd.0007133","journal-title":"PLoS Negl Trop Dis"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1039\/d0dt03963b","volume":"50","author":"F Rivas","year":"2021","unstructured":"Rivas F, Medeiros A, Quiroga C et al (2021) New Pd-Fe ferrocenyl antiparasitic compounds with bioactive 8-hydroxyquinoline ligands: a comparative study with their Pt-Fe analogues. Dalton Trans 50:1651\u20131665. https:\/\/doi.org\/10.1039\/d0dt03963b","journal-title":"Dalton Trans"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/353772a0","volume":"353","author":"JCBM Zomerdijk","year":"1991","unstructured":"Zomerdijk JCBM, Kieft R, Borst P (1991) Efficient production of functional mRNA mediated by RNA polymerase I in Trypanosoma brucei. Nature 353:772\u2013775. https:\/\/doi.org\/10.1038\/353772a0","journal-title":"Nature"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1128\/AAC.45.4.1168-1173.2001","volume":"45","author":"D Sereno","year":"2001","unstructured":"Sereno D, Roy G, Loup Lemesre J et al (2001) DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antimicrob Agents Chemother 45:1168\u20131173. https:\/\/doi.org\/10.1128\/AAC.45.4.1168-1173.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0001323","volume":"5","author":"G Michel","year":"2011","unstructured":"Michel G, Ferrua B, Lang T et al (2011) Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro. PLoS Negl Trop Dis 5:1\u20137. https:\/\/doi.org\/10.1371\/journal.pntd.0001323","journal-title":"PLoS Negl Trop Dis"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0003556","volume":"9","author":"JQ Reim\u00e3o","year":"2015","unstructured":"Reim\u00e3o JQ, Oliveira JC, Trinconi CT et al (2015) Generation of luciferase-expressing leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging. PLoS Negl Trop Dis 9:1\u201316. https:\/\/doi.org\/10.1371\/journal.pntd.0003556","journal-title":"PLoS Negl Trop Dis"},{"key":"10_CR23","first-page":"265","volume-title":"Methods molecular biology","author":"N Santar\u00e9m","year":"2019","unstructured":"Santar\u00e9m N, Tavares J, Cordeiro-da-Silva A (2019) In vitro infections of macrophage-like cell lines with leishmania infantum for drug screening. In: Clos J (ed) Methods molecular biology, vol 1971. Springer, New York, pp 265\u2013277"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"18989","DOI":"10.1038\/s41598-019-55474-3","volume":"9","author":"D Mendes Costa","year":"2019","unstructured":"Mendes Costa D, Cec\u00edlio P, Santar\u00e9m N et al (2019) Murine infection with bioluminescent Leishmania infantum axenic amastigotes applied to drug discovery. Sci Rep 9:18989. https:\/\/doi.org\/10.1038\/s41598-019-55474-3","journal-title":"Sci Rep"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/jac\/dkp500","volume":"65","author":"K Seifert","year":"2010","unstructured":"Seifert K, Escobar P, Croft SL (2010) In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent. J Antimicrob Chemother 65:508\u2013511. https:\/\/doi.org\/10.1093\/jac\/dkp500","journal-title":"J Antimicrob Chemother"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1007\/s00436-018-6059-4","volume":"117","author":"M Van den Kerkhof","year":"2018","unstructured":"Van den Kerkhof M, Van Bockstal L, Gielis JF et al (2018) Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility. Parasitol Res 117:3601\u20133612. https:\/\/doi.org\/10.1007\/s00436-018-6059-4","journal-title":"Parasitol Res"},{"key":"10_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007885","volume":"13","author":"S Hendrickx","year":"2019","unstructured":"Hendrickx S, Van Bockstal L, Caljon G, Maes L (2019) In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates. PLoS Negl Trop Dis 13:e0007885. https:\/\/doi.org\/10.1371\/journal.pntd.0007885","journal-title":"PLoS Negl Trop Dis"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0020-7519(96)00037-9","volume":"26","author":"S M\u00e9ndez","year":"1996","unstructured":"M\u00e9ndez S, Nell M, Alunda JM (1996) Leishmania infantum: infection of macrophages in vitro with promastigotes. Int J Parasitol 26:619\u2013622. https:\/\/doi.org\/10.1016\/0020-7519(96)00037-9","journal-title":"Int J Parasitol"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1017\/S0031182016002031","volume":"145","author":"S Hendrickx","year":"2016","unstructured":"Hendrickx S, Guerin PJ, Caljon G et al (2016) Evaluating drug resistance in visceral leishmaniasis: the challenges. Parasitology 145:453\u2013463. https:\/\/doi.org\/10.1017\/S0031182016002031","journal-title":"Parasitology"},{"key":"10_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001469","volume":"6","author":"D Moreira","year":"2012","unstructured":"Moreira D, Santar\u00e9m N, Loureiro I et al (2012) Impact of continuous axenic cultivation in Leishmania infantum virulence. PLoS Negl Trop Dis 6:e1469. https:\/\/doi.org\/10.1371\/journal.pntd.0001469","journal-title":"PLoS Negl Trop Dis"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/pim.12056","volume":"35","author":"KS Ali","year":"2013","unstructured":"Ali KS, Rees RC, Terrell-Nield C, Ali SA (2013) Virulence loss and amastigote transformation failure determine host cell responses to Leishmania mexicana. Parasite Immunol 35:441\u2013456. https:\/\/doi.org\/10.1111\/pim.12056","journal-title":"Parasite Immunol"},{"key":"10_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005924","volume":"11","author":"GD Melo","year":"2017","unstructured":"Melo GD, Goyard S, Lecoeur H et al (2017) New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence. PLoS Negl Trop Dis 11:e0005924. https:\/\/doi.org\/10.1371\/journal.pntd.0005924","journal-title":"PLoS Negl Trop Dis"},{"key":"10_CR33","doi-asserted-by":"publisher","first-page":"19.2.1","DOI":"10.1002\/0471142735.im1902s108","volume":"108","author":"DL Sacks","year":"2015","unstructured":"Sacks DL, Melby PC (2015) Animal models for the analysis of immune responses to leishmaniasis. Curr Protoc Immunol 108:19.2.1\u201319.2.24. https:\/\/doi.org\/10.1002\/0471142735.im1902s108","journal-title":"Curr Protoc Immunol"},{"key":"10_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1087057106296498","volume":"2","author":"Y Sui","year":"2007","unstructured":"Sui Y, Wu Z (2007) Alternative statistical parameter for high-throughput screening assay quality assessment. J Biomol Screen 2:229\u2013234. https:\/\/doi.org\/10.1177\/1087057106296498","journal-title":"J Biomol Screen"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang JH, Chung TDY, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67\u201373. https:\/\/doi.org\/10.1177\/108705719900400206","journal-title":"J Biomol Screen"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00418-014-1215-0","volume":"142","author":"D Prieto","year":"2014","unstructured":"Prieto D, Aparicio G, Morande PE, Zolessi FR (2014) A fast, low cost, and highly efficient fluorescent DNA labeling method using methyl green. Histochem Cell Biol 142:335\u2013345. https:\/\/doi.org\/10.1007\/s00418-014-1215-0","journal-title":"Histochem Cell Biol"},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.freeradbiomed.2014.05.007","volume":"73","author":"AF Sousa","year":"2014","unstructured":"Sousa AF, Gomes-Alves AG, Ben\u00edtez D et al (2014) Genetic and chemical analyses reveal that trypanothione synthetase but not glutathionylspermidine synthetase is essential for Leishmania infantum. Free Radic Biol Med 73:229\u2013238. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.05.007","journal-title":"Free Radic Biol Med"},{"key":"10_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0166-6851(02)00033-6","volume":"121","author":"RPP Soares","year":"2002","unstructured":"Soares RPP, Macedo ME, Ropert C et al (2002) Leishmania chagasi: Lipophosphoglycan characterization and binding to the midgut of the sand fly vector Lutzomyia longipalpis. Mol Biochem Parasitol 121:213\u2013224. https:\/\/doi.org\/10.1016\/S0166-6851(02)00033-6","journal-title":"Mol Biochem Parasitol"},{"key":"10_CR39","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1128\/AAC.01781-15","volume":"60","author":"D Tegazzini","year":"2016","unstructured":"Tegazzini D, D\u00edaz R, Aguilar F et al (2016) A replicative in vitro assay for drug discovery against leishmania donovani. Antimicrob Agents Chemother 60:3524\u20133532. https:\/\/doi.org\/10.1128\/AAC.01781-15","journal-title":"Antimicrob Agents Chemother"},{"key":"10_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.exppara.2007.06.012","volume":"118","author":"C Yao","year":"2008","unstructured":"Yao C, Chen Y, Sudan B et al (2008) Leishmania chagasi: Homogenous metacyclic promastigotes isolated by buoyant density are highly virulent in a mouse model. Exp Parasitol 118:129\u2013133. https:\/\/doi.org\/10.1016\/j.exppara.2007.06.012","journal-title":"Exp Parasitol"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1128\/AAC.00866-09","volume":"53","author":"RI Da Luz","year":"2009","unstructured":"Da Luz RI, Vermeersch M, Dujardin JC et al (2009) In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells. Antimicrob Agents Chemother 53:5197\u20135203. https:\/\/doi.org\/10.1128\/AAC.00866-09","journal-title":"Antimicrob Agents Chemother"},{"key":"10_CR42","first-page":"475","volume":"47","author":"S Mandal","year":"2009","unstructured":"Mandal S, Maharjan M, Ganguly S et al (2009) High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric beta-lactamase assay. Indian J Exp Biol 47:475\u2013479","journal-title":"Indian J Exp Biol"},{"key":"10_CR43","unstructured":"Promega (2021) Choosing a luciferase reporter assay. In: A reporter assay comparison guide. https:\/\/worldwide.promega.com\/resources\/guides\/cell-biology\/choosing-a-luciferase-reporter-assay\/. Accessed 1 Apr 2021"}],"container-title":["Methods in Molecular Biology","Bioluminescence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2453-1_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T19:31:34Z","timestamp":1657654294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2453-1_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071624524","9781071624531"],"references-count":43,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2453-1_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"13 July 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}